Third Harmonic Bio

THRD52

$13.50arrow_drop_up5.88%$0.75

THRD52

$13.50

arrow_drop_up5.88%$0.75

Performance History

Key Stats
Open	$12.50
Prev. Close	$12.75
EPS	-0.82
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	12.50	13.29
52 Week Range	5.76	16.94

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.82

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Third Harmonic Bio (THRD)

Third Harmonic Bio Inc (THRD) is a leading biotechnology company that focuses on developing innovative therapies for the treatment of various diseases. The company's stock price history has shown steady growth over the years, reflecting the success and potential of its groundbreaking research and development efforts. Investors have been optimistic about the future prospects of THRD, leading to a surge in its stock price.

THRD is committed to revolutionizing the field of biotechnology by utilizing a unique approach called third harmonic generation. This cutting-edge technology allows the company to target specific disease-causing cells without harming healthy cells. The potential applications of this technology are vast, with the ability to treat a wide range of diseases, including cancer, autoimmune disorders, and genetic diseases.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Ms. Natalie C. Holles
Headquarters: Cambridge
Employees: 31
Exchange: NASDAQ

Keep an eye on Third Harmonic Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Third Harmonic Bio 's (THRD) price per share?

The current price per share for Third Harmonic Bio (THRD) is $13.5. The stock has seen a price change of $0.75 recently, indicating a 5.88% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Third Harmonic Bio (THRD)?

For Third Harmonic Bio (THRD), the 52-week high is $16.94, which is 25.48% from the current price. The 52-week low is $5.76, the current price is 134.17% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Third Harmonic Bio (THRD) a growth stock?

Third Harmonic Bio (THRD) has shown an average price growth of 0.41% over the past three years. It has received a score of 97 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Third Harmonic Bio as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Third Harmonic Bio (THRD) stock price performance year to date (YTD)?

As of the latest data, Third Harmonic Bio (THRD) has a year-to-date price change of 20.11%. Over the past month, the stock has experienced a price change of 13.26%. Over the last three months, the change has been 4.25%. Over the past six months, the figure is 49.5%.

help

Is Third Harmonic Bio (THRD) a profitable company?

Third Harmonic Bio (THRD) has a net income of -$30.82M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$43.95M. Furthermore, the EBITDA is -$46.56M.

help

What is the market capitalization of Third Harmonic Bio (THRD)?

Third Harmonic Bio (THRD) has a market capitalization of $540.02M. The average daily trading volume is 468.77K, indicating the stock's liquidity and investor engagement.